Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity
Authors: Cava, Antonio L.; Shi, Fu-Dong
Source: Current Medicinal Chemistry, Volume 13, Number 13, June 2006 , pp. 1557-1566(10)
Publisher: Bentham Science Publishers
Abstract:Recent studies have raised great interest in the modulation of autoimmune responses by manipulation of immunoregulatory cells. Several lymphocyte subpopulations responsible for the induction and maintenance of immune tolerance have been extensively studied, and much has been learned about their properties. Lately, a series of attempts to harness the immunoregulatory activities of these cells for therapeutic purposes has proven successful in preclinical studies. The development of new strategies for the expansion of glycolipid-induced activation of NKT cells and antigenspecific regulatory T cells represent examples that have generated considerable interest and that are leading to the development of immunoregulatory cell-based approaches translating the findings from the bench to the bedside. This review highlights the advances, obstacles and limitations of these studies and critically discusses the most recent findings in this rapidly expanding field.
Document Type: Research Article
Affiliations: Department of Medicine of the David Geffen School of Medicine, University of California, Los Angeles, California 90095-1670, USA.
Publication date: June 1, 2006
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.